Navigation Links
BioReliance Appoints Executive Chairman to be Interim CEO and Announces Recent Senior Executive Additions
Date:10/29/2007

ROCKVILLE, Md., Oct. 29 /PRNewswire/ -- BioReliance Corporation today appointed its Executive Chairman, Charles C. Harwood, Jr., to the additional post of Interim CEO, following the announced resignation of Tim Derrington from the CEO position. In addition, BioReliance announced that three senior executives have joined the company since June: David E. Onions, Ph.D., as Chief Scientific Officer, David S. Walker as Chief Financial Officer, and Darryl L. Goss as Vice President of Global Process Excellence.

BioReliance is a portfolio company of Avista Capital Partners and was purchased in April 2007 from Invitrogen Corporation. Charles Harwood comments, "While Tim Derrington's personal decision to leave BioReliance was not anticipated at the time of the acquisition, the Board does not believe it will affect the timetable for strengthening the senior executive team and setting a clear course for BioReliance as a stand-alone company."

In addition to serving as Executive Chairman of BioReliance, Mr. Harwood serves on the boards of several other healthcare companies, including ATCC and RadPharm, Inc., and recently formalized a relationship with Avista to support their healthcare team as a Healthcare Industry Advisor. From 2002 to 2006, Mr. Harwood served as President and CEO of Focus Diagnostics, Inc., a specialty diagnostics company offering advanced laboratory testing services and diagnostic products. Previously, from 1993 to 2001, Mr. Harwood held several positions, including Chief Financial Officer and SVP of Venture Development, at Covance, Inc., one of the largest drug development services companies. Mr. Harwood began his healthcare career in the medical equipment field working for the Medical Products Group of Hewlett-Packard Company. He received an MBA from Harvard Business School and a Bachelor of Arts from Stanford University.

David Onions is the Chief Scientific Officer and a member of the Board of BioReliance. He was formerly Chief Medical Officer of Invitrogen and before that Director of the Leukaemia Research Fund's Virus Centre and Professor of Veterinary Virology at the University of Glasgow. Dr. Onions was a founding director of Q-One Biotech which was acquired by BioReliance in 2003. He is a member, or former member, of several advisory groups including the FDA's Xenotransplantation Advisory Committee and the World Health Organisation's Expert Advisory Panel on Biological Standardization. Dr. Onions is a Fellow of the Royal Society of Edinburgh, Fellow of the Academy of Medical Sciences, and a Fellow of the Royal Society of Arts.

David Walker serves as the Chief Financial Officer of BioReliance. Previously, Mr. Walker was the CFO of American Type Culture Collection, or ATCC. From 2003 to 2006, Mr. Walker was the VP and CFO of Focus Diagnostics. He served as SVP and CFO of Restoragen, Inc. from 2000 to 2003. Prior to 2000, Mr. Walker held various senior finance positions with Arbor Acres, Inc., Fisons plc, and The Boots Company, plc. Mr. Walker graduated from Nottingham Trent University in Nottingham, England, with a degree in Accounting and Finance and is a qualified member of the Chartered Institute of Management Accountants in England.

Darryl Goss has joined BioReliance as the VP of Global Process Excellence. Prior to joining BioReliance, Mr. Goss was SVP and Chief Operating Officer of Esoterix, Inc. following its acquisition by LabCorp. From 2000 to 2005, he held a variety of other senior executive roles at Esoterix including SVP of Business Operations and Chief Information Officer. From 1993 to 2000, Mr. Goss worked at Covance Central Laboratory Services, Inc., serving in such roles as VP of Information Technology & Services. Prior to 1993, he held various information technology and business development positions with Smith Kline Beecham Clinical Laboratories, Guidance Opportunity, Inc., Beatrice Hunt-Wesson and IBM. Mr. Goss has a Masters of Business Administration from the University of Chicago and completed post-graduate work in Advanced Management from Oxford University in Oxford, England. In addition, Mr. Goss graduated from the University of California Davis with a Bachelor of Arts.

About BioReliance

BioReliance Corporation is a leading contract services organization, offering more than 1,000 tests or services related to biologics safety testing, in vitro and in vivo toxicology, viral manufacturing and lab animal health diagnostics for the biopharmaceutical and pharmaceutical industries. BioReliance has its primary facilities in Rockville, Maryland; Glasgow, Scotland; and Stirling, Scotland. Headquartered in Rockville, Maryland, BioReliance employs over 700 people globally. For more information, visit http://www.bioreliance.com.

Contact:

David Walker, BioReliance, 301-610-2866, david.walker@bioreliance.com


'/>"/>
SOURCE BioReliance Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Where Burnt Out Executives De-stress in Natures Lap
2. Asian Business Executives Urged to Be Eco-friendly
3. BMA Welcomes Scottish Executives Move to Raise the Purchase Age of Cigarettes
4. Bruce Vladeck Will Hold Fort (interim) of UMDNJ
5. Interim WHO Chief Confirms No radical changes in WHO
6. Interim OPD saves the day for patients
7. PM announces a new health care order for India
8. Ramdoss Announces Introduction of RCH-II
9. Britain Announces Third Transfusion Related Mad Cow Case
10. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
11. Tibet Announces the Dalai Lama’s Tour of South Americ
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... ... February 05, 2016 , ... Health and wellness is a topic that ... the event they are experiencing an illness. Migraines are a severe form of a ... with migraines would not wish the pain on their worst enemy, the feeling can ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... ... Care for Patients with Rare Diseases, a continuing medical education (CME) event presented ... the first of its kind—and a first for ACCORD, whose mission is to ...
(Date:2/5/2016)... ... 2016 , ... KICVentures ( http://www.kicventures.com ) announced today that ... York City on Thursday, January 21, 2016. Kingsley R. Chin, the CEO ... the varsity Columbia soccer program) spoke at the event, offering professional insight based ...
(Date:2/5/2016)... ... February 05, 2016 , ... Susan Polk Health Insurance Company ... users can expect to see in 2016. To view the report, see below, or ... directly impact many San Luis Obispo seniors who rely on Medicare health insurance and ...
(Date:2/4/2016)... ... February 04, 2016 , ... Dr. Carol Francis and 30 ... 19-21, 2016, in Southern California . The International Hypnosis Federation 2016 Conference "It's ... speakers, including Clinical Psychologist and Hypnotherapist Dr. Carol Francis (topics and ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... -- Patients in Alabama seeking prostate care ... longer have to travel out of state. Vituro Health ... Centers of Alabama to provide a total prostate management ... Alabama is known throughout ... cancer using many different modalities. They are the largest and ...
(Date:2/5/2016)... 5, 2016 Aethlon Medical, Inc. (Nasdaq: AEMD ... CEO, will be presenting at Source Capital Group,s 2016 Disruptive ... at 2:15 p.m. ET on Wednesday, February 10, ... discussion taking place at 3:15 p.m. ET. http://www.aethlonmedical.com ... hour after the conclusion of the live event. The panel ...
(Date:2/5/2016)... BEIJING , Feb. 5, 2016 ... ("Dehaier Medical" or the "Company"), which develops, markets ... products in China and ... restructuring plan which aims to concentrate the Company,s ... wearable sleep respiratory business and to focus more ...
Breaking Medicine Technology: